Variant report
Variant | rs3802543 |
---|---|
Chromosome Location | chr10:46169092-46169093 |
allele | C/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:19)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:19 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | POLR2A | chr10:46167256-46169209 | H1-hESC | embryonic stem cell: | n/a | n/a |
2 | CTCF | chr10:46167043-46169438 | A549 | lung: | n/a | n/a |
3 | MAX | chr10:46167471-46169126 | HepG2 | liver: | n/a | chr10:46168328-46168337 chr10:46168302-46168312 |
4 | CREB1 | chr10:46167581-46169142 | HepG2 | liver: | n/a | n/a |
5 | E2F6 | chr10:46167430-46169092 | H1-hESC | embryonic stem cell: | n/a | chr10:46168306-46168316 chr10:46168302-46168311 chr10:46168344-46168354 chr10:46168226-46168236 |
6 | RFX5 | chr10:46167017-46169117 | IMR90 | lung: | n/a | chr10:46168338-46168347 chr10:46168334-46168349 |
7 | FOXA2 | chr10:46168729-46169141 | A549 | lung: | n/a | n/a |
8 | POLR2A | chr10:46169069-46169144 | MCF10A-Er-Src | breast: | n/a | n/a |
9 | POLR2A | chr10:46167570-46169180 | HepG2 | liver: | n/a | n/a |
10 | RFX5 | chr10:46167020-46169234 | SK-N-SH | brain: | n/a | chr10:46168338-46168347 chr10:46168334-46168349 |
11 | FOXA1 | chr10:46168631-46169110 | HepG2 | liver: | n/a | n/a |
12 | NFIC | chr10:46167506-46169239 | ECC-1 | luminal epithelium: | n/a | chr10:46168908-46168925 chr10:46168909-46168925 |
13 | MXI1 | chr10:46167668-46169106 | HepG2 | liver: | n/a | chr10:46168338-46168353 |
14 | FOXA1 | chr10:46168730-46169117 | HepG2 | liver: | n/a | n/a |
15 | NFIC | chr10:46168617-46169109 | HepG2 | liver: | n/a | chr10:46168908-46168925 chr10:46168909-46168925 |
16 | NFIC | chr10:46167494-46169206 | ECC-1 | luminal epithelium: | n/a | chr10:46168908-46168925 chr10:46168909-46168925 |
17 | MAX | chr10:46167490-46169137 | HepG2 | liver: | n/a | chr10:46168328-46168337 chr10:46168302-46168312 |
18 | FOXA1 | chr10:46167945-46169100 | HepG2 | liver: | n/a | n/a |
19 | MTA3 | chr10:46167442-46169256 | GM12878 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ZFAND4 | TF binding region |
rs_ID | r2[population] |
---|---|
rs10508896 | 0.88[ASN][1000 genomes] |
rs1060848 | 1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs12098366 | 0.88[ASN][1000 genomes] |
rs12761573 | 0.88[ASN][1000 genomes] |
rs12762495 | 0.82[ASN][1000 genomes] |
rs12763285 | 0.88[ASN][1000 genomes] |
rs12764693 | 0.82[ASN][1000 genomes] |
rs12765244 | 0.88[ASN][1000 genomes] |
rs12766764 | 0.88[ASN][1000 genomes] |
rs12771659 | 0.83[EUR][1000 genomes] |
rs12772102 | 0.88[ASN][1000 genomes] |
rs12774453 | 0.88[ASN][1000 genomes] |
rs12775527 | 0.82[ASN][1000 genomes] |
rs12776291 | 0.88[ASN][1000 genomes] |
rs12777172 | 0.88[ASN][1000 genomes] |
rs12778143 | 0.88[ASN][1000 genomes] |
rs12779005 | 0.88[ASN][1000 genomes] |
rs12779198 | 0.82[ASN][1000 genomes] |
rs12779204 | 0.88[ASN][1000 genomes] |
rs12779637 | 0.88[ASN][1000 genomes] |
rs12779976 | 0.88[ASN][1000 genomes] |
rs12781186 | 0.82[ASN][1000 genomes] |
rs12781506 | 0.88[ASN][1000 genomes] |
rs12783233 | 0.82[ASN][1000 genomes] |
rs17157859 | 1.00[AFR][1000 genomes] |
rs17157861 | 1.00[AFR][1000 genomes] |
rs17157880 | 0.82[ASN][1000 genomes] |
rs17157884 | 0.82[ASN][1000 genomes] |
rs17157885 | 0.82[ASN][1000 genomes] |
rs17157887 | 0.82[ASN][1000 genomes] |
rs17157890 | 0.89[AFR][1000 genomes];0.82[ASN][1000 genomes] |
rs17157898 | 0.88[ASN][1000 genomes] |
rs17157919 | 0.88[ASN][1000 genomes] |
rs17157928 | 0.88[ASN][1000 genomes] |
rs17157931 | 0.88[ASN][1000 genomes] |
rs17157941 | 0.91[AMR][1000 genomes];1.00[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs17157944 | 0.91[AMR][1000 genomes];1.00[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs17157945 | 0.91[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs17157971 | 0.89[EUR][1000 genomes] |
rs17158898 | 0.81[EUR][1000 genomes] |
rs17159059 | 0.89[EUR][1000 genomes] |
rs17159087 | 0.89[EUR][1000 genomes] |
rs17159090 | 0.84[AMR][1000 genomes];0.94[EUR][1000 genomes] |
rs17159113 | 0.94[EUR][1000 genomes] |
rs17159119 | 0.85[EUR][1000 genomes] |
rs17451208 | 0.88[ASN][1000 genomes] |
rs17696005 | 1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs17696011 | 1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs17696112 | 1.00[AMR][1000 genomes];0.94[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs17768650 | 1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs17768692 | 1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs17768852 | 0.82[AMR][1000 genomes];0.81[EUR][1000 genomes] |
rs1868622 | 0.80[EUR][1000 genomes] |
rs2197982 | 0.92[EUR][1000 genomes] |
rs33997730 | 0.80[ASN][1000 genomes] |
rs34011467 | 0.88[ASN][1000 genomes] |
rs34138033 | 0.88[ASN][1000 genomes] |
rs34144887 | 0.88[ASN][1000 genomes] |
rs34163035 | 0.88[ASN][1000 genomes] |
rs34195613 | 0.88[ASN][1000 genomes] |
rs34309840 | 0.88[ASN][1000 genomes] |
rs34383275 | 0.88[ASN][1000 genomes] |
rs34516867 | 0.88[ASN][1000 genomes] |
rs34539215 | 0.88[ASN][1000 genomes] |
rs34574958 | 0.88[ASN][1000 genomes] |
rs34604216 | 0.88[ASN][1000 genomes] |
rs34618850 | 0.88[ASN][1000 genomes] |
rs34670342 | 0.88[ASN][1000 genomes] |
rs34793991 | 0.88[ASN][1000 genomes] |
rs34897497 | 0.82[ASN][1000 genomes] |
rs35001302 | 0.88[ASN][1000 genomes] |
rs35003524 | 0.88[ASN][1000 genomes] |
rs35034867 | 0.88[ASN][1000 genomes] |
rs35036712 | 0.88[ASN][1000 genomes] |
rs35047800 | 0.88[ASN][1000 genomes] |
rs35049879 | 0.88[ASN][1000 genomes] |
rs35070150 | 0.88[ASN][1000 genomes] |
rs35131026 | 0.82[ASN][1000 genomes] |
rs35150810 | 0.88[ASN][1000 genomes] |
rs35183191 | 0.88[ASN][1000 genomes] |
rs35183751 | 0.88[ASN][1000 genomes] |
rs35331393 | 0.88[ASN][1000 genomes] |
rs35506889 | 0.88[ASN][1000 genomes] |
rs35585999 | 0.88[ASN][1000 genomes] |
rs35626777 | 0.88[ASN][1000 genomes] |
rs35629170 | 0.88[ASN][1000 genomes] |
rs35639934 | 0.88[ASN][1000 genomes] |
rs35670420 | 0.88[ASN][1000 genomes] |
rs35713143 | 0.88[ASN][1000 genomes] |
rs35750365 | 0.82[ASN][1000 genomes] |
rs35775604 | 0.83[ASN][1000 genomes] |
rs35824277 | 0.88[ASN][1000 genomes] |
rs35902429 | 0.82[ASN][1000 genomes] |
rs35916836 | 0.88[ASN][1000 genomes] |
rs35934513 | 0.88[ASN][1000 genomes] |
rs35968565 | 0.88[ASN][1000 genomes] |
rs36052429 | 0.82[ASN][1000 genomes] |
rs36053776 | 0.88[ASN][1000 genomes] |
rs36054203 | 0.88[ASN][1000 genomes] |
rs36070535 | 0.82[ASN][1000 genomes] |
rs36074276 | 0.88[ASN][1000 genomes] |
rs36100685 | 0.88[ASN][1000 genomes] |
rs36102549 | 0.83[ASN][1000 genomes] |
rs36109121 | 0.88[ASN][1000 genomes] |
rs41301625 | 0.91[AMR][1000 genomes];1.00[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs41301629 | 0.87[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs41301631 | 0.87[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs4418752 | 1.00[EUR][1000 genomes] |
rs4442500 | 0.88[ASN][1000 genomes] |
rs4576771 | 1.00[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs55814534 | 0.84[AMR][1000 genomes];0.94[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs56034881 | 0.84[AMR][1000 genomes];0.89[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs56277479 | 0.84[AMR][1000 genomes];0.94[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs56388386 | 0.94[EUR][1000 genomes] |
rs57279747 | 0.94[EUR][1000 genomes] |
rs58849111 | 0.89[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs59689764 | 0.82[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs60791882 | 0.88[ASN][1000 genomes] |
rs71496608 | 0.82[ASN][1000 genomes] |
rs71496609 | 0.82[ASN][1000 genomes] |
rs71496610 | 0.82[ASN][1000 genomes] |
rs71496611 | 0.82[ASN][1000 genomes] |
rs71496612 | 0.88[ASN][1000 genomes] |
rs71496613 | 0.88[ASN][1000 genomes] |
rs71496614 | 0.88[ASN][1000 genomes] |
rs71496618 | 0.88[ASN][1000 genomes] |
rs71496619 | 0.88[ASN][1000 genomes] |
rs71496620 | 0.88[ASN][1000 genomes] |
rs71496621 | 0.88[ASN][1000 genomes] |
rs71496622 | 0.88[ASN][1000 genomes] |
rs71496623 | 0.88[ASN][1000 genomes] |
rs71496624 | 0.88[ASN][1000 genomes] |
rs71496625 | 0.88[ASN][1000 genomes] |
rs71499567 | 0.88[ASN][1000 genomes] |
rs73291115 | 0.88[ASN][1000 genomes] |
rs73291121 | 0.88[ASN][1000 genomes] |
rs73291122 | 0.88[ASN][1000 genomes] |
rs73291195 | 0.88[ASN][1000 genomes] |
rs73291198 | 0.88[ASN][1000 genomes] |
rs73292811 | 1.00[EUR][1000 genomes] |
rs73292848 | 1.00[EUR][1000 genomes] |
rs74128806 | 0.94[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs7898761 | 0.84[AMR][1000 genomes];0.97[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs9422439 | 0.88[ASN][1000 genomes] |
rs9422440 | 0.88[ASN][1000 genomes] |
rs9422441 | 0.88[ASN][1000 genomes] |
rs9422442 | 0.88[ASN][1000 genomes] |
rs9422650 | 0.88[ASN][1000 genomes] |
rs9422651 | 0.88[ASN][1000 genomes] |
rs9422652 | 0.88[ASN][1000 genomes] |
rs9422653 | 0.88[ASN][1000 genomes] |
rs9422654 | 0.88[ASN][1000 genomes] |
rs9422655 | 0.88[ASN][1000 genomes] |
rs9422657 | 0.88[ASN][1000 genomes] |
rs9422658 | 0.88[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv993428 | chr10:45742877-46224333 | Enhancers Active TSS Weak transcription ZNF genes & repeats Bivalent/Poised TSS Strong transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 19 gene(s) | inside rSNPs | diseases |
2 | nsv895108 | chr10:45878908-46224333 | Active TSS Weak transcription Enhancers ZNF genes & repeats Strong transcription Bivalent Enhancer Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 16 gene(s) | inside rSNPs | diseases |
3 | nsv895109 | chr10:45882741-46210665 | Weak transcription Strong transcription Enhancers Active TSS Genic enhancers Flanking Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 12 gene(s) | inside rSNPs | diseases |
4 | nsv895112 | chr10:46012620-46202216 | Flanking Active TSS Weak transcription Strong transcription Enhancers Active TSS ZNF genes & repeats Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 9 gene(s) | inside rSNPs | diseases |
5 | esv3392795 | chr10:46147995-46170942 | Enhancers Active TSS Flanking Active TSS Weak transcription ZNF genes & repeats Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 5 gene(s) | inside rSNPs | diseases |
6 | nsv1045014 | chr10:46148750-46814526 | Active TSS Strong transcription ZNF genes & repeats Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 24 gene(s) | inside rSNPs | diseases |
7 | esv2754498 | chr10:46148750-47136996 | Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Strong transcription Flanking Active TSS Active TSS Enhancers Bivalent/Poised TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 47 gene(s) | inside rSNPs | diseases |
8 | nsv540591 | chr10:46153700-47140487 | Weak transcription Enhancers Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats Genic enhancers Strong transcription Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 47 gene(s) | inside rSNPs | diseases |
9 | nsv1044906 | chr10:46153700-47148281 | Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Strong transcription Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 47 gene(s) | inside rSNPs | diseases |
10 | nsv540592 | chr10:46153700-47148281 | Enhancers Weak transcription Active TSS ZNF genes & repeats Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers Bivalent/Poised TSS Strong transcription Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 47 gene(s) | inside rSNPs | diseases |
11 | nsv870020 | chr10:46158215-47148490 | Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Strong transcription Active TSS ZNF genes & repeats Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 47 gene(s) | inside rSNPs | diseases |
12 | nsv1040524 | chr10:46160537-47122043 | Bivalent/Poised TSS ZNF genes & repeats Enhancers Weak transcription Strong transcription Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 45 gene(s) | inside rSNPs | diseases |
13 | nsv1038499 | chr10:46160537-47140487 | Flanking Active TSS Bivalent Enhancer Weak transcription Bivalent/Poised TSS Enhancers Strong transcription Flanking Bivalent TSS/Enh Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 47 gene(s) | inside rSNPs | diseases |
14 | nsv540593 | chr10:46160537-47140487 | Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Bivalent Enhancer ZNF genes & repeats Bivalent/Poised TSS Genic enhancers Active TSS Strong transcription Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 47 gene(s) | inside rSNPs | diseases |
15 | nsv1055132 | chr10:46160537-47148281 | Weak transcription Bivalent/Poised TSS Enhancers ZNF genes & repeats Genic enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 47 gene(s) | inside rSNPs | diseases |
16 | nsv540594 | chr10:46160537-47148281 | Active TSS Strong transcription Weak transcription Flanking Active TSS Bivalent Enhancer Enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 47 gene(s) | inside rSNPs | diseases |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:46167000-46169200 | Active TSS | iPS-20b Cell Line | embryonic stem cell |
2 | chr10:46167000-46169200 | Active TSS | Fetal Kidney | kidney |
3 | chr10:46168400-46169200 | Flanking Active TSS | NHEK | skin |
4 | chr10:46168600-46169200 | Enhancers | Spleen | Spleen |
5 | chr10:46168600-46169200 | Flanking Bivalent TSS/Enh | HepG2 | liver |
6 | chr10:46168800-46169200 | Enhancers | Primary monocytes fromperipheralblood | blood |
7 | chr10:46168800-46169200 | Enhancers | Primary T cells fromperipheralblood | blood |
8 | chr10:46168800-46169200 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
9 | chr10:46168800-46169200 | Enhancers | Right Ventricle | heart |
10 | chr10:46168800-46169800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr10:46169000-46169200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
12 | chr10:46169000-46169200 | Flanking Active TSS | iPS-15b Cell Line | embryonic stem cell |
13 | chr10:46169000-46169200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
14 | chr10:46169000-46169200 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
15 | chr10:46169000-46169200 | Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
16 | chr10:46169000-46169200 | Active TSS | Primary T helper naive cells from peripheral blood | blood |
17 | chr10:46169000-46169200 | Enhancers | Adipose Nuclei | Adipose |
18 | chr10:46169000-46169200 | Flanking Active TSS | Liver | Liver |
19 | chr10:46169000-46169200 | Enhancers | Fetal Heart | heart |
20 | chr10:46169000-46169200 | Enhancers | Fetal Muscle Leg | muscle |
21 | chr10:46169000-46169200 | Enhancers | Stomach Mucosa | stomach |